Quick Picks - In an all-stock merger announced Thursday morning, BioCryst Pharmaceuticals (NASDAQ:BCRX) will acquire privately-held Presidio, Inc, creating a new business entity to focus on oral Hepatitis … Continue Reading
Read nowLong Ideas - Deerfield Capital reported a 6.2% stake in InterMune (NASDAQ:ITMN) on Tuesday, causing shares of the biotechnology company to climb 10% in the following trading session. … Continue Reading
Read now- Shares of St. Jude Medical (NYSE:STJ) opened 6% lower Wednesday morning following the company’s quarterly report and conference call, which included discussion of a potential … Continue Reading
Read nowLong Ideas - On Tuesday, Gattex (teduglutide) received a unanimous recommendation for approval from the FDA’s Gastrointestinal Drugs Advisory Committee, suggesting that the FDA may officially approve the … Continue Reading
Read now- The FDA has raised safety concerns about tumors spotted in patients treated with the developmental LDL-lowering therapy, Kynamro. The drug is under review after a … Continue Reading
Read now- Shares of ArQule (NASDAQ:ARQL) are up 8% on news that the FDA has agreed to a Special Protocol Assessment for the company’s planned Phase III tivantinib trial. … Continue Reading
Read nowLong Ideas - Developers of potential Hepatitis C (HCV) treatments are among the most-traded in the healthcare industry on Monday, following an announcement from Abbot Laboratories (NYSE:ABT) that … Continue Reading
Read now